KERRI HENDERSON: Open Payments
NPI 1447611009 · HANNIBAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 21 payments from 13 companies in 2025. Trend: 2023 $279 · 2024 $580 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $88 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
| Exact Sciences Corporation | 2 | $37 |
| ABBVIE INC. | 1 | $32 |
| Astellas Pharma US Inc | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Novo Nordisk Inc | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Abbott Laboratories | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
Products named: LEQVIO, REPATHA, Cologuard Collection Kit, EVENITY, UBRELVY, Veozah, REXULTI, Ozempic.
Industry payments across MO — which companies pay providers there.
